# IRESSA

NDC: 0310-0482
Generic name: Gefitinib
Labeler / Manufacturer: AstraZeneca Pharmaceuticals LP
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, COATED
Routes: ORAL
Marketing started: 20150713

FDA application: NDA206995

## Active ingredients

- GEFITINIB: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0310-0482"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0310-0482
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=827d60e8-7e07-41b7-c28b-49ef1c4a5a41